Oxy 186
Alternative Names: Oxy-186Latest Information Update: 28 Mar 2025
At a glance
- Originator MAX BioPharma
- Developer MAX BioPharma; National Institute of Infectious Diseases
- Class Antineoplastics; Antivirals; Small molecules; Sterols
- Mechanism of Action Hedgehog cell signalling pathway inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer; COVID 2019 infections
Most Recent Events
- 28 Mar 2025 No recent reports of development identified for preclinical development in COVID-2019-infections in Japan (PO)
- 28 Mar 2025 No recent reports of development identified for preclinical development in COVID-2019-infections in USA (PO)
- 28 Mar 2025 No recent reports of development identified for preclinical development in COVID-2019-infections(Prevention) in Japan (PO)